@Sparkswa enlighten us as to why CYP’s performance is dependent on meso, particularly since consistency in CYP”s product overcomes a key criticism the FDA had of meso given the lack of consistency in their product.
re years to come, the ARDS trial is recruiting now so When you say years, how many years do you think that short trial will take? You seem to know more than mgmt and the investigators on this so will be interesting to hear.
Ann: Quarterly Activity Report & Appendix 4C, page-20
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
-0.010(3.85%) |
Mkt cap ! $44.90M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 26.5¢ | 25.0¢ | $5.869K | 22.42K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 29342 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 15.47pm 11/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |